Latest Research

Our mission is to ensure that the evolution of CyberKnife technology leads to the best treatment options for all patients.

Sponsored Studies
The following Clinical Studies are sponsored by Accuray, Inc.:

• CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
• CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
• CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Cancer
• A Prospective Evaluation of Outcomes of Radiosurgical Treatment of Early Stage Non-Small Cell Lung Cancer (NSCLC)

(PubMed provides links to downloadable PDFs which are usually available from the individual journals for a fee. Summaries of the articles are also available to review, free of charge. ) * Prostate, Lung, Brain, Spine, Liver, Pancreas, Kidney Information